ENANTA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.56 USD | -1.31% |
|
+4.95% | +44.10% |
| 04-30 | Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer | CI |
| 02-09 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 26/04/2024 | 29/04/2024 | 30/04/2024 | 01/05/2024 | |
|---|---|---|---|---|
| Last | 12.37 $ | 13.25 $ | 13.74 $ | 13.56 $ |
| Volume | 67 161 | 245 390 | 148 402 | 139 736 |
| Change | -0.88% | +7.11% | +3.70% | -1.31% |
| Opening | 12.48 | 12.35 | 13.22 | 13.73 |
| High | 12.65 | 13.34 | 14.10 | 14.27 |
| Low | 12.20 | 12.35 | 12.87 | 13.51 |
Performance
| 1 day | -1.31% | ||
| 1 week | +4.95% | ||
| Current month | -1.31% | ||
| 1 month | -20.33% | ||
| 3 months | +6.10% | ||
| 6 months | +51.85% | ||
| Current year | +44.10% | ||
| 1 year | -63.85% | ||
| 3 years | -73.28% | ||
| 5 years | -84.13% | ||
| 10 years | -63.71% |
Volumes
marketsDaily volume
139 736
Estimated daily volume
139 736
Avg. Volume 20 sessions
142 767
Daily volume ratio
0.98
Avg. Volume 20 sessions USD
1 935 920.52
Record volume 1
6 068 746
Record volume 2
4 926 408
Record volume 3
2 205 168
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
286 875 129
Net sales (USD)
79 204 000
Number of employees
145
Sales / Employee (USD)
546 234
Free-Float
93.9 %
Free-Float capitalization (USD)
269 376 844
Average Daily Capital Traded
0.67%
Highs and lows
1 week
12.20
14.27
1 month
12.2017.60
Current year
9.2417.80
1 year
8.0837.14
3 years
8.08102.00
5 years
8.08102.00
10 years
8.08127.77
Indicators
Moving average 5 days
13.08
Moving average 20 days
14.79
Moving average 50 days
14.76
Moving average 100 days
12.98
Price spread / (MMA5)
-3.54%
Price spread / (MMA20)
+9.04%
Price spread / (MMA50)
+8.82%
Price spread / (MMA100)
-4.25%
STIM
RSI 9 days
46.01
RSI 14 days
44.95
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.31% | +4.95% | +44.10% | -63.85% | 287M | ||
| +0.50% | -3.28% | +0.67% | +22.60% | 42.4B | ||
| +1.45% | -1.98% | +45.89% | -6.76% | 40.04B | ||
| +2.89% | +5.76% | -6.20% | +17.68% | 28.31B | ||
| +1.25% | -2.53% | +6.55% | +54.32% | 24.94B | ||
| +4.18% | +4.28% | -21.66% | -25.71% | 18.96B | ||
| +2.58% | +0.21% | +29.96% | +92.93% | 12.3B | ||
| +1.61% | -2.82% | -1.57% | +22.40% | 11.95B | ||
| +8.88% | +7.65% | +16.03% | +9.92% | 11.32B | ||
| +16.22% | +15.65% | -4.80% | -7.28% | 11.55B | ||
| +1.13% | +3.11% | -4.38% | -7.23% | 9.5B | ||
| -0.94% | +18.86% | +7.53% | -35.02% | 6.6B | ||
| +0.16% | -0.99% | +23.62% | -16.00% | 6.54B | ||
| +4.09% | +9.03% | +35.30% | +62.70% | 6.62B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| +4.24% | +1.32% | -14.98% | +20.54% | 6.27B | ||
| Average | +2.93% | +3.19% | +10.40% | +9.42% | ||
| Weighted average by Cap. | +2.75% | +1.30% | +9.40% | +15.22% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
18822bce7c427f4acf38.k7GmU5xkH5BAjUTrAA5Mv6778XlDoqnrVXZWhrFfIYA.3uCWCe41KNl1uiKjNUQJ5cS_xCpu4OjfMgFnzf47YtP70u41rhNb3HPgAQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 21:00:00 | 13.56 | 16,043 | 105,301 |
| 20:59:58 | 13.55 | 100 | 89,258 |
| 20:59:58 | 13.55 | 100 | 89,158 |
| 20:59:58 | 13.53 | 260 | 89,058 |
| 20:59:58 | 13.53 | 100 | 88,798 |
| 20:59:51 | 13.54 | 141 | 88,698 |
| 20:59:50 | 13.51 | 100 | 88,557 |
| 20:59:45 | 13.54 | 100 | 88,457 |
| 20:59:44 | 13.54 | 100 | 88,357 |
| 20:59:12 | 13.57 | 100 | 88,257 |
Monthly variations
Annual change
| 2024 | +44.10% | ||
| 2023 | -79.77% | ||
| 2022 | -37.79% | ||
| 2021 | +77.62% | ||
| 2020 | -31.85% | ||
| 2019 | -12.78% | ||
| 2018 | +20.71% | ||
| 2017 | +75.16% | ||
| 2016 | +1.45% | ||
| 2015 | -35.06% | ||
| 2014 | +86.40% | ||
| 2013 | +58.79% |
- Stock Market
- Equities
- ENTA Stock
- Quotes Enanta Pharmaceuticals, Inc.
